Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diclofenac versus sham gel for painful foot osteoarthritis
ACTRN12626000654358Phase 4Not yet recruiting
- Sponsor
- University of Melbourne
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of diclofenac in hallux rigidus and Midfoot osteoarthritis (2 arms), sponsored by University of Melbourne. Primary endpoint: Severity of foot pain during walking. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
diclofenac
03
Conditions
hallux rigidusMidfoot osteoarthritis
Beyond the preview
Go deeper on ACTRN12626000654358.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12626000654358.